Four butyrolactones and diverse bioactive secondary metabolites from terrestrial Aspergillus flavipes MM2: isolation and structure determination
暂无分享,去创建一个
[1] F. Mourão,et al. Antioxidant Activity of Agaricus brasiliensis Basidiocarps on Different Maturation Phases , 2009, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[2] N. Boonyuen,et al. Butyrolactones from the fungus Aspergillus terreus BCC 4651. , 2010, Chemical & pharmaceutical bulletin.
[3] N. Boonyuen,et al. Butenolide and furandione from an endophytic Aspergillus terreus. , 2010, Chemical & pharmaceutical bulletin.
[4] T. Bau,et al. Antitumor components from Naematoloma fasciculare. , 2009, Journal of microbiology and biotechnology.
[5] Tomoo Hosoe,et al. Aspergillus novofumigatus から分離されたジヒドロテレインおよびテレインの血小板凝集作用に関する検討 , 2009 .
[6] W. Ratnasooriya,et al. Inhibition of lipid peroxidation by extracts of Pleurotus ostreatus , 2009 .
[7] Yuemao Shen,et al. Secondary metabolites of Aspergillus sp. F1, a commensal fungal strain of Trewia nudiflora , 2009, Natural product research.
[8] Tomoo,et al. Inhibitory effects of dihydroterrein and terrein isolated from Aspergillus novofumigatus on platelet aggregation , 2009 .
[9] Fang Mei-zhen. Active Components and Free Radical Scavenging Activity of Fermentation Mycelia and Broth of Paecilomyces tenuipes , 2009 .
[10] Zhu Weiming. Cytotoxic metabolites from symbiotic fungus Penicillium sp.HK13-8 with Rhizophora stylosa , 2009 .
[11] Jay D Keasling,et al. Developing Aspergillus as a host for heterologous expression. , 2009, Biotechnology advances.
[12] A. Tripathi,et al. Aspernolides A and B, butenolides from a marine-derived fungus Aspergillus terreus. , 2009, Phytochemistry.
[13] S. Hasnain,et al. Antifungal and antibacterial activities of indigenous Streptomyces isolates from saline farmlands: prescreening, ribotyping and metabolic diversity , 2008 .
[14] J. Na,et al. Terrein inhibits keratinocyte proliferation via ERK inactivation and G2/Mcell cycle arrest , 2008, Experimental dermatology.
[15] C. Shao,et al. A new isoprenyl phenyl ether compound from mangrove fungus , 2007, Chemistry of Natural Compounds.
[16] R. Tan,et al. Biology and chemistry of endophytes. , 2006, Natural product reports.
[17] P. Proksch,et al. Frontiers in Marine Biotechnology , 2006 .
[18] Jørn Smedsgaard,et al. Phenotypic taxonomy and metabolite profiling in microbial drug discovery. , 2005, Natural product reports.
[19] Kathrine B. Christensen,et al. Identity and effects of quorum-sensing inhibitors produced by Penicillium species. , 2005, Microbiology.
[20] H. Laatsch. Marine Bacterial Metabolites , 2005 .
[21] Y. C. Song,et al. Endophytic naphthopyrone metabolites are co-inhibitors of xanthine oxidase, SW1116 cell and some microbial growths. , 2004, FEMS microbiology letters.
[22] Mark S Butler,et al. The role of natural product chemistry in drug discovery. , 2004, Journal of natural products.
[23] I. Yoo,et al. Terrein: a new melanogenesis inhibitor and its mechanism , 2004, Cellular and Molecular Life Sciences CMLS.
[24] D. Hazuda,et al. Isolation, Structure, and HIV‐1 Integrase Inhibitory Activity of Xanthoviridicatin E and F, Two Novel Fungal Metabolites Produced by Penicillium chrysogenum. , 2004 .
[25] A. Marsaioli,et al. Terreinol-a novel metabolite from Aspergillus terreus: structure and 13C labeling , 2004 .
[26] Kristian Fog Nielsen,et al. Fungal metabolite screening: database of 474 mycotoxins and fungal metabolites for dereplication by standardised liquid chromatography-UV-mass spectrometry methodology. , 2003, Journal of chromatography. A.
[27] D. Grant,et al. Characterization of stereochemistry and molecular conformation using solid-state NMR tensors. , 2001, Journal of the American Chemical Society.
[28] G. Strobel,et al. Jesterone and hydroxy-jesterone antioomycete cyclohexenone epoxides from the endophytic fungus Pestalotiopsis jesteri. , 2001, Phytochemistry.
[29] J. Clardy,et al. CR377, a new pentaketide antifungal agent isolated from an endophytic fungus. , 2000, Journal of natural products.
[30] J. M. Babu,et al. Butyrolactones from Aspergillus terreus. , 2000, Chemical & pharmaceutical bulletin.
[31] T. Kitamura,et al. Butyrolactone I induces cyclin B1 and causes G2/M arrest and skipping of mitosis in human prostate cell lines. , 1999, Cancer letters.
[32] N. Saijo,et al. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines. , 1996, Anticancer research.
[33] M. Kitagawa,et al. A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. , 1994, Oncogene.
[34] A. Okuyama,et al. Inhibition of cell cycle oscillation of DNA replication by a selective inhibitor of the cdc2 kinase family, butyrolactone I, in Xenopus egg extracts. , 1994, Biochemical and biophysical research communications.
[35] I. Kubo,et al. Naturally occurring antiacne agents. , 1994, Journal of natural products.
[36] M. Kitagawa,et al. Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. , 1993, Oncogene.
[37] W. Chilton,et al. PHYTOTOXIC METABOLITES OF PHOMA SORGHINA, A NEW FOLIAR PATHOGEN OF POKEWEED , 1992 .
[38] G. J. Thomas. Herbicidal activity of 6-methylanthranilic acid and analogs , 1984 .
[39] K. Arai,et al. Metabolic Products of Aspergillus terreus. IX. Biosynthesis of Butyrolactone Derivatives isolated from Strains IFO 8835 and 4100 , 1983 .
[40] N. Ojima,et al. New metabolites from Aspergillus terreus related to the biosynthesis of aspulvinones , 1976 .
[41] S. Takenaka,et al. Structures of pulvinone derivatives from Aspergillus terreus , 1975 .
[42] J. Nilsson,et al. The analgesic properties of methylsalicylic acids. , 1970, Acta pharmaceutica Suecica.
[43] K. Raper,et al. The genus Aspergillus , 1966 .
[44] B. K. Bakshi,et al. A new species of Aspergillus , 1961 .
[45] P. Burkholder,et al. Antibiotic Activity of some Marine Algae of Puerto Rico , 1960 .
[46] G. Martin. The Genus Aspergillus. , 1946, Science.